DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Lin HC, Huang YT, Yang YY. , et al.
Beneficial effects of dual vascular endothelial growth factor receptor/fibroblast growth factor receptor inhibitor brivanib alaninate in cirrhotic portal hypertensive rats.
J Gastroenterol Hepatol 2014;
29 (05) 1073-1082
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.